Nothing Special   »   [go: up one dir, main page]

AUPP656298A0 - A method of diagnosis - Google Patents

A method of diagnosis

Info

Publication number
AUPP656298A0
AUPP656298A0 AUPP6562A AUPP656298A AUPP656298A0 AU PP656298 A0 AUPP656298 A0 AU PP656298A0 AU PP6562 A AUPP6562 A AU PP6562A AU PP656298 A AUPP656298 A AU PP656298A AU PP656298 A0 AUPP656298 A0 AU PP656298A0
Authority
AU
Australia
Prior art keywords
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP6562A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Newcastle University of Upon Tyne
Original Assignee
University of Newcastle, The
Newcastle University of Upon Tyne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Newcastle, The, Newcastle University of Upon Tyne filed Critical University of Newcastle, The
Priority to AUPP6562A priority Critical patent/AUPP656298A0/en
Publication of AUPP656298A0 publication Critical patent/AUPP656298A0/en
Priority to AU11408/00A priority patent/AU1140800A/en
Priority to PCT/AU1999/000911 priority patent/WO2000023613A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AUPP6562A 1998-10-19 1998-10-19 A method of diagnosis Abandoned AUPP656298A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPP6562A AUPP656298A0 (en) 1998-10-19 1998-10-19 A method of diagnosis
AU11408/00A AU1140800A (en) 1998-10-19 1999-10-19 A method of assessing a matter associated with parturition in a pregnant individual
PCT/AU1999/000911 WO2000023613A1 (en) 1998-10-19 1999-10-19 A method of assessing a matter associated with parturition in a pregnant individual

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP6562A AUPP656298A0 (en) 1998-10-19 1998-10-19 A method of diagnosis

Publications (1)

Publication Number Publication Date
AUPP656298A0 true AUPP656298A0 (en) 1998-11-05

Family

ID=3810783

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP6562A Abandoned AUPP656298A0 (en) 1998-10-19 1998-10-19 A method of diagnosis

Country Status (2)

Country Link
AU (1) AUPP656298A0 (en)
WO (1) WO2000023613A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006084109A2 (en) * 2005-02-02 2006-08-10 Pro Term, Inc. Salivary protease assays for identifying increased risk of preterm delivery induced by premature rupture of fetal membranes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641636A (en) * 1994-05-20 1997-06-24 University Of Pennsylvania Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity

Also Published As

Publication number Publication date
WO2000023613A1 (en) 2000-04-27

Similar Documents

Publication Publication Date Title
AU696462B2 (en) Diagnostic method
AU6236699A (en) A method of homogenization
AU4917697A (en) Method of making a toothbrush
AU9227198A (en) A method for improving skin condition
AU3091599A (en) Method of making dimethylnaphtalenes
AUPP713498A0 (en) A method of detecting blood
AU3590199A (en) Method for diagnosing a vascular condition
AU3938299A (en) Method of altering heartbeat
AU6105199A (en) Diagnostic method
AU2150600A (en) System and method for providing a dental diagnosis
AU6386498A (en) A method of transformation
AU2194801A (en) Diagnostic method
AU6000600A (en) Diagnostic method
AU9119998A (en) Method of time-to-talk calculation
AUPP612798A0 (en) Diagnostic method
AUPN058895A0 (en) Diagnostic method
AUPP656298A0 (en) A method of diagnosis
AU1984900A (en) Diagnostic method
AU7908198A (en) A method for pre-fibrillation of lyocell
AUPN192695A0 (en) Diagnosis method
AUPO933597A0 (en) Diagnostic method
AUPO899997A0 (en) A method of diagnosis
AU2002320652A1 (en) A method of diagnosis
AUPP486498A0 (en) A method of transformation
AUPP644498A0 (en) A method of screening - ii

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 1140800

Country of ref document: AU